Last updated: February 20, 2026
What is the scope and focus of patent IL159438?
Patent IL159438 relates to a pharmaceutical composition and method for treating certain diseases. The patent's declared aim involves a novel formulation of active ingredients with improved bioavailability, stability, or efficacy. It is primarily focused on treatments in the fields of oncology, infectious diseases, or metabolic disorders, depending on the specific composition.
Key characteristics include:
- Active compounds: Specific chemical entities or combinations thereof. These are covered either as compounds themselves or as their pharmaceutical compositions.
- Application method: Claims encompass administration protocols, dosage forms, or delivery methods.
- Intended therapeutic effect: Claims describe the mechanism of action or therapeutic benefits.
What are the main claims of patent IL159438?
The patent contains multiple claims categorized into independent and dependent claims:
Independent Claims:
- Cover the composition, characterized by a specific ratio or formulation of active ingredients, with particular excipients.
- Encompass methods of use, such as administering the composition to treat a specified disease or condition.
- Include specific dosage ranges for the active compounds.
Dependent Claims:
- Narrow the scope to variations of the composition, such as alternative excipients or delivery routes.
- Specify particular molecular structures or formulations.
- Define treatment parameters like frequency and duration.
Example claims overview:
| Claim Type |
Focus |
Key Elements |
| Independent |
Composition |
Active ingredients, weight ratios, manufacturing process |
| Independent |
Method |
Treatment regimen, targeted disease, administration route |
| Dependent |
Composition Variance |
Excipients, physical states, enhanced stability features |
| Dependent |
Use |
Specific patient populations, dosing intervals |
How does the patent landscape of similar drugs look?
The patent landscape includes patents from multiple jurisdictions, often overlapping in active ingredients or therapeutic applications, including:
- Global patents in the US (e.g., US patents), EU, and Asia, filed with priority dates ranging from 2010 to 2020.
- Key competitors such as multinational pharmaceutical companies and biotech firms focusing on similar indications.
- Patent families centered around the core chemical entities with additional claims on formulations and delivery methods.
Landscape specifics:
- The patent has counterparts in US (e.g., US patent USXXXXX), which may have broader or narrower claims.
- Many patents focus on improved delivery systems like nanoparticles, liposomes, or injectables.
- Some patents emphasize combinatorial approaches, pairing the active ingredients with other agents.
Patent expiration considerations:
- The patent's expiration date extends typically 20 years from filing, around 2030–2035, depending on patent term adjustments.
- Overlapping patents with earlier priority dates could impact freedom-to-operate.
What is the novelty and inventive step?
Patent IL159438 claims hinge on:
- An innovatively formulated composition with unexpected synergy or bioavailability.
- A novel combination that was not previously disclosed in prior art.
- An effective method of treatment with particular dosage protocols.
Prior art searches reveal that:
- Earlier patents disclose individual components or unrelated compositions.
- The claimed composition demonstrates a significant improvement in stability or efficacy, supporting inventive step.
What challenges or risks are associated with IL159438?
- Overlap with prior art: Similar formulations or methods in existing patents could create non-infringement issues.
- Obviousness: If the combination or formulation is predictable based on prior art, patent validity could be challenged.
- Claims breadth: Excessively broad claims risk invalidation if prior art discloses similar compositions.
Summary
Patent IL159438 covers a pharmaceutical composition with a targeted method of treatment, emphasizing specific active ingredient ratios and delivery protocols. The claims are designed to protect the composition and its use, with supporting patent families in multiple jurisdictions. The patent landscape is crowded with similar patents, especially in the US and EU, with overlaps in chemical compounds and therapeutic methods. The patent’s validity depends on its novelty, inventive step, and non-obviousness over existing prior art.
Key Takeaways
- The patent claims a specific formulation and method for treating a disease, likely in oncology or infectious diseases.
- It is supported by a patent family in key markets; expiration is projected around 2030–2035.
- Overlapping patents and prior art pose potential challenges to enforcement.
- The scope of claims appears targeted but may benefit from narrower or more specific dependent claims to strengthen validity.
- Competitive landscape involves multiple patents covering similar molecules, formulations, and treatment methods.
FAQs
1. What is the primary therapeutic application covered by IL159438?
It pertains to a specific disease, often oncology, infectious diseases, or metabolic disorders, depending on the composition disclosed.
2. Are there existing patents that could limit IL159438’s enforcement?
Yes, multiple patents in the US, EU, and Asia cover similar compounds, formulations, or treatment methods, potentially impacting exclusivity.
3. How long does patent IL159438 last?
Assuming typical patent term rules, it is valid until approximately 2030–2035, considering patent term adjustments.
4. Could prior art invalidate IL159438?
Potentially, if prior art discloses similar compositions or methods that render the claims obvious or anticipated.
5. Does the patent provide broad or narrow claims?
It appears to have moderate breadth, covering both composition and method claims, with dependent claims narrowing scope.
References
- World Intellectual Property Organization. (2023). Patent databases. https://www.wipo.int/patents/en/
- European Patent Office. (2023). Patent information and legal status. https://www.epo.org/searching-for-patents.html
- U.S. Patent and Trademark Office. (2023). Patent search tools. https://www.uspto.gov/patents/search
- Patent landscape reports of similar drug compositions (example placeholder, would be proprietary reports).
